Multihance Drug Interactions: 41 Major, 100 Moderate
Multihance (Gadobenate Dimeglumine) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Multihance. Always confirm against the full prescribing information.
100 interactions
Adenosine
The risk or severity of QTc prolongation can be increased when Adenosine is combined with Gadobenic acid.
Level 2 evidence
Amifampridine
The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Amifampridine.
Level 2 evidence
Amikacin
Gadobenic acid may decrease the excretion rate of Amikacin which could result in a higher serum level.
Level 2 evidence
Amisulpride
The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Amisulpride.
Level 1 evidence
Amitriptyline
The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Gadobenic acid.
Level 2 evidence
Atropine
The risk or severity of QTc prolongation can be increased when Atropine is combined with Gadobenic acid.
Level 2 evidence
Azithromycin
The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Gadobenic acid.
Level 2 evidence
Bedaquiline
The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Bedaquiline.
Level 1 evidence
Berotralstat
The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Berotralstat.
Level 2 evidence
Capreomycin
Gadobenic acid may decrease the excretion rate of Capreomycin which could result in a higher serum level.
Level 2 evidence
Carbamazepine
Gadobenic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Level 2 evidence
Carbinoxamine
The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Carbinoxamine.
Level 2 evidence
Enter your NPI to unlock 5 major interactions for Multihance
Multihance (Gadobenate Dimeglumine) has 691 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Multihance (Gadobenate Dimeglumine) has 41 major, 100 moderate, and 550 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Multihance. Always confirm against the full prescribing information.